Ownership

Paul B. Manning - Director at Candel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: CADL on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Paul B. Manning - trading volume in the past year for Candel Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+1.25M	100%	$6.00	+$7.5M
Sells
Net	+1.25M	100%		+$7.5M

Holdings reported by Paul B. Manning for Candel Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	1.68M	$10.1M	$6.00	Dec 16, 2024	Direct
Common Stock	1.3M	$7.82M	$6.00	Dec 16, 2024	By BKB Growth Investments, LLC
Common Stock	1.14M	$6.85M	$6.00	Dec 16, 2024	By Paul B. Manning Revocable Trust
Stock Option (Right to Buy)	14.2K			Jun 26, 2024	Direct	Common Stock

Transactions reported by Paul B. Manning for Candel Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.